Eligible members in these markets can receive up to four months of medication for free as an incentive to switch to simvastatin from brand-name statins.
WellPoint NextRx will include simvastatin, the generic equivalent of Merck's cholesterol drug Zocor, to the list of drugs included in WellPoint's GenericSelect program in seven additional states: Connecticut, Indiana, Kentucky, Maine, New Hampshire, Ohio, and Virginia. Through GenericSelect, eligible members in these markets can receive up to four months of medication for free as an incentive to switch to simvastatin from brand-name statins. GenericSelect is designed to provide improved access to affordable generics used to treat high cholesterol, high blood pressure, diabetes, arthritis pain, and depression. The drugs on the GenericSelect list are among the most commonly prescribed medications for these conditions. Simvastatin will be available to WellPoint members in these new markets by the end of March. WellPoint NextRx is a wholly owned PBM division of Indianapolis-based WellPoint Inc.